Thomas Patton Net Worth

The estimated Net Worth of Thomas M Patton is at least 42 千$ dollars as of 9 March 2020. Mr. Patton owns over 2,000 units of ElectroCore Inc stock worth over 42,000$ and over the last 9 years he sold ECOR stock worth over 0$. In addition, he makes 0$ as Independent Director at ElectroCore Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Patton ECOR stock SEC Form 4 insiders trading

Thomas has made over 2 trades of the ElectroCore Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 2,000 units of ECOR stock worth 24,400$ on 9 March 2020.

The largest trade he's ever made was buying 5,000 units of ElectroCore Inc stock on 13 February 2018 worth over 51,000$. On average, Thomas trades about 280 units every 30 days since 2015. As of 9 March 2020 he still owns at least 7,000 units of ElectroCore Inc stock.

You can see the complete history of Mr. Patton stock trades at the bottom of the page.

Thomas Patton biography

Thomas M. Patton J.D. serves as Independent Director of the Company. Mr. Thomas Patton has served as a member of the Board since April 2, 2020. He is a seasoned healthcare executive and board member with operational, strategic, financial, legal, compliance and transactional experience, from start-ups to growth companies, both public and private. He last served as President and Chief Executive Officer of CAS Medical Systems, a publicly traded developer and distributor of patient monitoring equipment, from 2010-2019. His prior experience includes as Co-Founder, President and CEO of QDX, Inc., a developer of unique micro-fluidic diagnostic technology utilizing digital imaging techniques for hematologic analysis, as President and Chief Operating Officer of Novametrix Medical Systems, Inc., and CEO of Wright Medical Technology, Inc. Mr. Patton has served on 11 separate boards of directors for both public and private medical products and services companies, and currently serves on the Board of Misonix, Inc., a publicly traded ultrasonic surgical tools and wound care company. The Board believes that Mr. Patton’s business and financial experience, as well as his medical device industry expertise, qualify him to serve on the Board.

How old is Thomas Patton?

Thomas Patton is 56, he's been the Independent Director of ElectroCore Inc since 2020. There are 12 older and 4 younger executives at ElectroCore Inc. The oldest executive at ElectroCore Inc is Peter Cuneo, 76, who is the Independent Director.

What's Thomas Patton's mailing address?

Thomas's mailing address filed with the SEC is 200 FORGE WAY, SUITE 205, , ROCKAWAY, NJ, 07866.

Insiders trading at ElectroCore Inc

Over the last 6 years, insiders at ElectroCore Inc have traded over 541,551$ worth of ElectroCore Inc stock and bought 3,996,513 units worth 5,852,816$ . The most active insiders traders include James L L Tullis、Joseph P Errico、Thomas J. Errico. On average, ElectroCore Inc executives and independent directors trade stock every 38 days with the average trade being worth of 422,718$. The most recent stock trade was executed by Thomas J. Errico on 15 August 2024, trading 5,000 units of ECOR stock currently worth 30,600$.

What does ElectroCore Inc do?

electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.

Complete history of Mr. Patton stock trades at Misonix Inc、ElectroCore Inc

ElectroCore Inc executives and stock owners

ElectroCore Inc executives and other stock owners filed with the SEC include:

• Daniel Goldberger,
  Chief Executive Officer, Director
• Joseph Errico,
  Director
• Brian Posner,
  Chief Financial Officer
• Daniel S. Goldberger,
  CEO & Director
• Brian M. Posner,
  CFO & Corp. Sec.
• Joseph P. Errico,
  Co-Founder, Principal Investor & Director
• Hans Vitzthum,
  Investor Relations
• Thomas Patton,
  Independent Director
• Stephen Ondra,
  Independent Director
• Trevor Moody,
  Independent Director
• John Gandolfo,
  Independent Director
• Thomas Errico,
  Independent Director
• Peter Cuneo,
  Independent Director
• Sylvester Steele,
  Vice President, General Manager of the Government Channels Business Unit
• Eric Liebler,
  Senior Vice President - Neurology
• Mike Romaniw,
  Executive Vice President - Systems & Operations
• Michael Atieh,
  Independent Chairman of the Board
• Dr. Peter S. Staats M.B.A., M.D.,
  Chief Medical Officer
• Eric J. Liebler,
  Sr. VP of Neurology
• Dr. Peter S. Staats,
  Chief Medical Officer
• Carrie Kochek,
  Sr. Director of HR
• Iain Strickland Ph.D.,
  VP of Global Sales & Strategy
• Jackie Dorsky,
  VP of Marketing
• Michael Romaniw,
  Exec. VP of Systems & Operations
• Julie Ann Goldstein,
  Director
• James L L Tullis,
  Director
• Nicholas Colucci,
  Director
• Global Health Innovation Fu...,
  10% owner
• Carrie Smith Cox,
  Director
• Ventures Ii, Llc Core,
  10% owner
• Francis R. Amato,
  Chief Executive Officer
• Peter S. Staats,
  Chief Medical Officer
• Glenn S. Vraniak,
  Chief Financial Officer
• Charles Steve Theofilos,
  
• Patricia Wilber,
  Director